Candriam S.C.A. - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 236 filers reported holding BEAM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,118,443
-24.7%
129,6650.0%0.02%
-26.7%
Q2 2023$4,140,203
+84.4%
129,665
+62.8%
0.03%
+87.5%
Q1 2023$2,245,241
-27.9%
79,6650.0%0.02%
-23.8%
Q4 2022$3,115,552
-17.9%
79,6650.0%0.02%
-22.2%
Q3 2022$3,795,000
+23.1%
79,6650.0%0.03%
+8.0%
Q2 2022$3,084,000
-30.2%
79,665
+3.3%
0.02%
-16.7%
Q1 2022$4,420,000
-28.1%
77,1470.0%0.03%
-23.1%
Q4 2021$6,148,000
-8.4%
77,1470.0%0.04%
-15.2%
Q3 2021$6,712,000
-32.4%
77,1470.0%0.05%
-32.4%
Q2 2021$9,930,00077,1470.07%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders